ADVFN - Advanced Financial Network.
HOME» NYSE » M » MJN Stock Price » MJN Stock News

Morgan Stanley Dw Str Sat Att Share News

 Ms Dw Str Sat Att Stock Price
MJN Stock Price
 Ms Dw Str Sat Att Stock Chart
MJN Stock Chart
 Ms Dw Str Sat Att Stock News
MJN Stock News
 Ms Dw Str Sat Att Company Information
MJN Company Information
 Ms Dw Str Sat Att Stock Trades
MJN Stock Trades

Mead Johnson 4Q Profit Falls 14% On Higher Costs

DOW JONES NEWSWIRES Mead Johnson Nutrition Co.'s (MJN) fourth-quarter earnings fell 14% as the company was hit by higher commodities costs and operating expenses. For the new year, the company projected per-share earnings of $3 to $3.10, below recent estimates of analysts polled by Thomson Reuters for $3.18. The company has been focusing on growth in emerging markets, and unveiled plans for a $325 million manufacturing and technology center in Singapore last month. Sales in Asia and Latin America -- which represent about two-thirds of the company's topline -- were up 17%. In North American and Europe, sales were up 6%. Mead Johnson reported a profit of $85.6 million, or 42 cents a share, down from $99.6 million, or 48 cents a share, a year earlier. Excluding litigation and restructuring-related costs, earnings were down at 52 cents from 57 cents. The company in October expected per-share earnings of 51 cents. Revenue increased 14% to $911.3 million amid higher prices and as volume rose 11%. Analysts polled by Thomson Reuters recently expected $896 million. Gross margin eased to 61.1% from 62.3% amid higher commodities costs. Overhead costs rose 8.6% while advertising and promotion expenses were up 15%. Research and development costs were up 39%. The company was hit with a short-lived recall of a batch of powdered Enfamil baby formula last month after a baby in Missouri died from a rare bacterial infection. Early this month U.S. health regulators said tests of the formula showed no signs of contamination and some major retailers began returning the product to their shelves. Mead was spun off from drug maker Bristol-Myers Squibb Co. (BMY) in 2009, one of the largest such deals of the last two decades. Shares closed Wednesday at $72.60 and were inactive premarket. The stock has recovered about 5.6% since hitting a more than 9-month low when the recall was unveiled. -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stock News for Morgan Stanley Dw Str Sat Att (MJN)
DateTimeHeadline
02/28/201418:05:07Mead Johnson Boosts Dividend by 10%
11/15/201309:15:02Lone Pine Capital 3Q 13F: Holdings As Of Sep 30
11/15/201309:14:57Lone Pine Capital 3Q 13F: Largest Sales
11/15/201309:03:11Chilton Investment Co. 3Q 13F: Largest Eliminations
11/15/201309:03:09Chilton Investment Co. 3Q 13F: Holdings As Of Sep 30
11/15/201309:03:09Chilton Investment Co. 3Q 13F: Holdings As Of Sep -2-
11/15/201309:01:33HBK Investments LP 3Q 13F: Holdings As Of Sep 30
11/15/201309:01:33HBK Investments LP 3Q 13F: Holdings As Of Sep 30 -2-
11/15/201308:39:36Kingdon Capital Management 3Q 13F: Largest Eliminations
11/15/201308:39:34Kingdon Capital Management 3Q 13F: Holdings As Of -2-
11/15/201308:39:33Kingdon Capital Management 3Q 13F: Holdings As Of Sep 30
11/15/201308:12:57Fidelity Management & Research Co. 3Q 13F: -2-
11/15/201308:12:57Fidelity Management & Research Co. 3Q 13F: Holdings As Of Sep...
11/15/201308:06:35Paulson & Co 3Q 13F: Largest Eliminations
11/15/201308:06:35Paulson & Co 3Q 13F: Holdings As Of Sep 30
11/15/201307:59:24Soros Fund Management 3Q 13F: Holdings As Of Sep 30
11/15/201307:59:24Soros Fund Management 3Q 13F: Holdings As Of Sep -2-
11/15/201307:07:21Two Sigma Investments 3Q 13F: Holdings As Of Sep -2-
11/15/201307:07:21Two Sigma Investments 3Q 13F: Holdings As Of Sep 30
11/15/201307:04:51Bridgewater Associates LP 3Q 13F: Largest Eliminations

Morgan Stanley Dw Str Sat Att and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad